GENB
Generate Biomedicines, Inc.
Key figures
| Metric | Latest |
|---|---|
| Revenue | $4.2MSep 2026 |
| Operating income | −$92MSep 2026 |
| Net income | −$88MSep 2026 |
| EPS | −$0.68Sep 2026 |
| Free cash flow | −$57MSep 2026 |
Generate Biomedicines, Inc.
| Metric | Latest |
|---|---|
| Revenue | $4.2MSep 2026 |
| Operating income | −$92MSep 2026 |
| Net income | −$88MSep 2026 |
| EPS | −$0.68Sep 2026 |
| Free cash flow | −$57MSep 2026 |